Endocrine side effects of immune checkpoint inhibitors

被引:17
|
作者
Cardona, Zulma [1 ]
Sosman, Jeffrey A. [2 ]
Chandra, Sunandana [2 ]
Huang, Wenyu [1 ]
机构
[1] Northwestern Univ, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Northwestern Univ, Div Hematol & Oncol, Feinberg Sch Med, Chicago, IL USA
来源
关键词
immune checkpoint inhibitor (ICI); endocrine side effects; hypophysitis; thyroiditis; type1; diabetes; adrenalitis; adrenal insufficiency; central diabetes insipidus; IPILIMUMAB-INDUCED HYPOPHYSITIS; CELL LUNG-CANCER; QUALITY-OF-LIFE; ADVERSE EVENTS; RETROSPECTIVE ANALYSIS; ADRENAL INSUFFICIENCY; THYROID ANTIBODIES; PD-1; EXPRESSION; NIVOLUMAB; MANAGEMENT;
D O I
10.3389/fendo.2023.1157805
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Immune checkpoint inhibitors (ICIs) have increasingly been the mainstay of treatment for numerous malignancies. However, due to their association with autoimmunity, ICIs have resulted in a variety of side effects that involve multiple organs including the endocrine system. In this review article, we describe our current understanding of the autoimmune endocrinopathies as a result of the use of ICIs. We will review the epidemiology, pathophysiology, clinical presentation, diagnosis, and management of the most commonly encountered endocrinopathies, including thyroiditis, hypophysitis, Type 1 diabetes, adrenalitis, and central diabetes insipidus.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Side effects of immune-checkpoint inhibitors: Can multiple side effects be seen in a patient?
    Ozyurt, Esra
    Ozcelik, Serhat
    Surmeli, Heves
    Celik, Mehmet
    Ayhan, Murat
    Ozcelik, Melike
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (02) : 462 - 465
  • [22] Immune Checkpoint Inhibitors and Systemic Side Effects: Overview for the Inpatient Dermatologist
    Taritsa, Iulianna
    Choi, Jennifer N.
    CURRENT DERMATOLOGY REPORTS, 2023, 12 (04) : 225 - 232
  • [23] Editorial: Immune checkpoint inhibitors in cancer: balancing the benefits with the side effects?
    Gomes-Lima, Cristiane J.
    Zhou, Wen
    Quandt, Zoe
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [24] Immune Checkpoint Inhibitors and Systemic Side Effects: Overview for the Inpatient Dermatologist
    Iulianna Taritsa
    Jennifer N. Choi
    Current Dermatology Reports, 2023, 12 : 225 - 232
  • [25] Efficacy and side effects of immune checkpoint inhibitors in the treatment of colorectal cancer
    Manz, Salomon M.
    Losa, Marco
    Fritsch, Ralph
    Scharl, Michael
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2021, 14
  • [26] Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors
    Moreira, Alvaro
    Loquai, Carmen
    Pfoefer, Claudia
    Kaehler, Katharina C.
    Knauss, Samuel
    Heppt, Markus V.
    Gutzmer, Ralf
    Dimitriou, Florentia
    Meier, Friedegund
    Mitzel-Rink, Heidrun
    Schuler, Gerold
    Terheyden, Patrick
    Thoms, Kai-Martin
    Tuerk, Matthias
    Dummer, Reinhard
    Zimmer, Lisa
    Schroeder, Rolf
    Heinzerling, Lucie
    EUROPEAN JOURNAL OF CANCER, 2019, 106 : 12 - 23
  • [27] Immune checkpoint inhibitors induced side effects of the peripheral nervous system
    Hundsberger, Thomas
    Schreiner, Bettina
    Roth, Patrick
    CURRENT OPINION IN NEUROLOGY, 2023, 36 (05) : 427 - 431
  • [28] Side effects of Immune Checkpoint Inhibitors: Diagnostics and Management-an Update
    Ertl, Carolin
    Tomsitz, Dirk
    Ben Khaled, Najib
    INNERE MEDIZIN, 2024, 65 (09): : 899 - 911
  • [29] Emerging Ocular Side Effects of Immune Checkpoint Inhibitors: A Comprehensive Review
    Wu, Kevin Y.
    Yakobi, Yoel
    Gueorguieva, Diana D.
    Mazerolle, Eric
    BIOMEDICINES, 2024, 12 (11)
  • [30] Hematological Side Effects of Immune Checkpoint Inhibitors: The Example of Immune-Related Thrombocytopenia
    Calvo, Roser
    FRONTIERS IN PHARMACOLOGY, 2019, 10